COMPANY PROFILE

Twist Bioscience

Explore full profile

Develops a proprietary semiconductor-based synthetic DNA manufacturing process

South San Francisco, United StatesFounded 2013Biotech & Life Sciences

Valuation $5.63B Market cap · Aug/2026

Revenue $445M Latest reported FY

At a glance

Founded: 2013
Headquarters: South San Francisco, United States
Listing: IPO 2018
Sector: Biotech & Life Sciences
Power Law: Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

News Twist Bioscience taps public markets for $250M share sale Aug 4, 2026

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

APARCH Venture Partners
AVAsset Management Ventures
PGPaladin Capital Group

Series B and later16 investors entered at this stage

TPTao Venture Partners
BNBoris Nikolic
AFARCH Overage Fund
FIFIS
WVWuXi Healthcare Ventures
JPJoby Pritzker
RSReinet Investments S.C.A.
DVDentsu Ventures
+C+ND Capital
3P3W Partners
BPBiomatics Capital Partners
IVIllumina Ventures
CMCormorant Asset Management
FCForesite Capital
YMYuri Milner
ILIllumina

Talent

Book a demo to see the people

Employees mapped 1,305 incl. 7 AI specialists

Founders /100 quality score

Key operators 6 quality /100

Potential founders likely future founders

Startup mafia 6 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 6 startups shown

Former Twist Bioscience employees who went on to found companies, sorted by Dealroom signal score.

Atlas Data StorageEst. 2025

Bill BanyaiUnited States

Brian MaurerUnited States

Signal score68

Switchback SystemsEst. 2019

Eugene MarshUnited States

Signal score62

RubrYc TherapeuticsEst. 2017

IBIsaac BrightUnited States

Signal score56

1 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country

Workforce by country

25 countries with
team presence

🇺🇸 United States84.6%

🇬🇧 United Kingdom2.7%

🇩🇪 Germany1.9%

🇸🇬 Singapore1.5%

🇮🇱 Israel1.3%

Top 5 of 25 shown

Web traffic by country

160K monthly visits
across markets

🇺🇸 United States30.4%

🇬🇧 United Kingdom7.3%

🇮🇳 India7.3%

🇳🇴 Norway5.5%

🇦🇺 Australia5.3%

Top 5 markets shown

Patents

Estimated portfolio value

$89M

108 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Twist Bioscience was the backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Twist Bioscience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

Where Twist Bioscience deploys vs peers

Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

Compare against